These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32164073)

  • 1. [Hepatotoxicity associated with tumor immune checkpoint inhibitors].
    Lei XH; Tang YY; Li J; Mao YM
    Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):175-178. PubMed ID: 32164073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury.
    Zen Y; Yeh MM
    Mod Pathol; 2018 Jun; 31(6):965-973. PubMed ID: 29403081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Toxicity with Cancer Checkpoint Inhibitor Therapy.
    Nadeau BA; Fecher LA; Owens SR; Razumilava N
    Semin Liver Dis; 2018 Nov; 38(4):366-378. PubMed ID: 30357774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies.
    Jennings JJ; Mandaliya R; Nakshabandi A; Lewis JH
    Expert Opin Drug Metab Toxicol; 2019 Mar; 15(3):231-244. PubMed ID: 30677306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the risk of hepatotoxicity induced by immune-checkpoint inhibitors and how can we avoid it?
    Tassinari E; Rosellini M; Marchetti A; Mollica V; Massari F
    Expert Opin Drug Metab Toxicol; 2024; 20(1-2):5-8. PubMed ID: 38299484
    [No Abstract]   [Full Text] [Related]  

  • 6. Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects.
    Lombardi A; Mondelli MU
    Aliment Pharmacol Ther; 2019 Oct; 50(8):872-884. PubMed ID: 31378985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
    De Martin E; Michot JM; Papouin B; Champiat S; Mateus C; Lambotte O; Roche B; Antonini TM; Coilly A; Laghouati S; Robert C; Marabelle A; Guettier C; Samuel D
    J Hepatol; 2018 Jun; 68(6):1181-1190. PubMed ID: 29427729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy Toxicities.
    Sanchez K; Page DB; Urba W
    Surg Oncol Clin N Am; 2019 Jul; 28(3):387-401. PubMed ID: 31079795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy is cancer treatment with a novel side-effect profile].
    Kondrup M; Raunkilde L; Svane IM; Schmidt H; Bastholt L
    Ugeskr Laeger; 2017 Oct; 179(40):. PubMed ID: 28992844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurological side effects of checkpoint inhibitors].
    Knauss S; Ginesta Roque L; Hühnchen P; Heinzerling L; Böhmerle W; Endres M
    Nervenarzt; 2019 Feb; 90(2):138-147. PubMed ID: 30073487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer.
    Suarez-Almazor ME; Kim ST; Abdel-Wahab N; Diab A
    Arthritis Rheumatol; 2017 Apr; 69(4):687-699. PubMed ID: 28085999
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of immunotherapy toxicities in older adults.
    Bhandari S; Gill AS; Perez CA; Jain D
    Semin Oncol; 2018 Aug; 45(4):226-231. PubMed ID: 30446167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity patterns associated with chemotherapy/immune checkpoint inhibitor combinations: a meta-analysis.
    Abdel-Rahman O
    Immunotherapy; 2019 Apr; 11(6):543-554. PubMed ID: 31135244
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic consequences of immune checkpoint inhibitors: A new challenge in clinical practice.
    Parthymos I; Liamis G; Dounousi E; Pentheroudakis G; Mauri D; Zarkavelis G; Florentin M
    Crit Rev Oncol Hematol; 2020 Jul; 151():102979. PubMed ID: 32480349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist.
    Lewis AL; Chaft J; Girotra M; Fischer GW
    Br J Anaesth; 2020 Mar; 124(3):251-260. PubMed ID: 32007241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms.
    Fessas P; Possamai LA; Clark J; Daniels E; Gudd C; Mullish BH; Alexander JL; Pinato DJ
    Immunology; 2020 Feb; 159(2):167-177. PubMed ID: 31646612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Etiology of Hypophysitis: Immune Checkpoint Inhibitors.
    Fernandes S; Varlamov EV; McCartney S; Fleseriu M
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):387-399. PubMed ID: 32741478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients.
    Imoto K; Kohjima M; Hioki T; Kurashige T; Kurokawa M; Tashiro S; Suzuki H; Kuwano A; Tanaka M; Okada S; Kato M; Ogawa Y
    Can J Gastroenterol Hepatol; 2019; 2019():6391712. PubMed ID: 31929981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging manifestations of immune-related adverse effects in checkpoint inhibitor therapies: A primer for the radiologist.
    Furtado VF; Melamud K; Hassan K; Rohatgi S; Buch K
    Clin Imaging; 2020 Jul; 63():35-49. PubMed ID: 32120311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxicities of immune checkpoint inhibitors and their management].
    Kostine M; Marabelle A; Schaeverbeke T; Kfoury M
    Med Sci (Paris); 2019 Dec; 35(12):949-956. PubMed ID: 31903899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.